Vitamin C had no activity by itself, but in two independent experiments, the combination of vitamin C with the first-line TB drugs, isoniazid and rifampicin, reduced the organ burdens faster than the two drugs without vitamin C

A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action

It's time to develop alternatives to antibiotics for small infections and to do so quickly

Scientists have peered deep into the heart of a key protein used in drug design and discovered dynamic structural features that may lead to new ways to target diseases

A new approach to reducing bulging tummy fats has shown promise in laboratory trials

Research provides a better understanding of how cancer spreads and may create new opportunities for cancer drug development.

Computational modeling key in design

Ovarian cancer is the most lethal gynecological malignancy and therapeutic options remain limited

Researchers from three different universities are  working together to develop and test what they think could be a better way to fight the flu

Ketamine was significantly more effective than a commonly used sedative in reducing suicidal thoughts in depressed patients

Labs at Duke and other academic centers collaborate to identify alternatives to antibiotics

Acute infections in male marmosets, a New World monkey, resemble the human illness the Zika virus creates in people